神经损伤与功能重建
神經損傷與功能重建
신경손상여공능중건
NEURAL INJURY AND FUNCTIONAL RECONSTRUCTION
2014年
3期
225-225,252
,共2页
鼠神经生长因子%高压氧%面神经炎
鼠神經生長因子%高壓氧%麵神經炎
서신경생장인자%고압양%면신경염
mouse nerve growth factor%hyperbaric oxygen therapy%facial neuritis
目的：观察鼠神经生长因子联合高压氧治疗慢性期面神经炎的疗效。方法：病程90~120 d 的面神经炎患者13例，均给予鼠神经生长因子联合高压氧治疗。治疗前后分别用 Ross 面神经分级系统进行综合评分，测定面神经复合肌肉动作电位（CMAP）波幅、瞬目反射 R1潜伏期。结果：治疗后综合分较治疗前升高，有显著性差异（=-22.3，＜0.01）。CMAP 波幅治疗后较治疗前升高，有显著性差异（=-6.9，＜0.01）；R1潜伏期治疗后较治疗前显著缩短，有显著性差异（=5.69，＜0.01）。结论：鼠神经生长因子联合高压氧治疗慢性期面神经炎有显著效果。
目的：觀察鼠神經生長因子聯閤高壓氧治療慢性期麵神經炎的療效。方法：病程90~120 d 的麵神經炎患者13例，均給予鼠神經生長因子聯閤高壓氧治療。治療前後分彆用 Ross 麵神經分級繫統進行綜閤評分，測定麵神經複閤肌肉動作電位（CMAP）波幅、瞬目反射 R1潛伏期。結果：治療後綜閤分較治療前升高，有顯著性差異（=-22.3，＜0.01）。CMAP 波幅治療後較治療前升高，有顯著性差異（=-6.9，＜0.01）；R1潛伏期治療後較治療前顯著縮短，有顯著性差異（=5.69，＜0.01）。結論：鼠神經生長因子聯閤高壓氧治療慢性期麵神經炎有顯著效果。
목적：관찰서신경생장인자연합고압양치료만성기면신경염적료효。방법：병정90~120 d 적면신경염환자13례，균급여서신경생장인자연합고압양치료。치료전후분별용 Ross 면신경분급계통진행종합평분，측정면신경복합기육동작전위（CMAP）파폭、순목반사 R1잠복기。결과：치료후종합분교치료전승고，유현저성차이（=-22.3，＜0.01）。CMAP 파폭치료후교치료전승고，유현저성차이（=-6.9，＜0.01）；R1잠복기치료후교치료전현저축단，유현저성차이（=5.69，＜0.01）。결론：서신경생장인자연합고압양치료만성기면신경염유현저효과。
ObjectiveTo observe the clinical efficacy of mouse nerve growth factor combined with hyperbaric oxygen therapy on patients of chronic facial neuritis. Methods: Clinical efficacy of 13 cases (the course was 90~120 d) were assessed before and after the therapy. All the cases had received mouse nerve growth factor combined with hyperbaric oxygen therapy. Ross Facial nerve grading system and CMAP amplitude, R1 incubation were used to evaluate the clinical effect scores. Results: The Composite score after treatment was significantly higher than that before treatment ( =-22.3 <0.01). The greater amplitude of CMAP and shorter latency R1 were found after treatment than that before treatment ( =5.69 <0.01). Conclusion: Mouse nerve growth factor combined with hyperbaric oxygen therapy was effective on patients with chronic facial neuritis.
